— Organigram (NASDAQ: OGI) reported a net loss from continuing operations of $22.46 million for the fourth quarter of 2019, vs. profit of $18.9 million last year.
— Loss per share was $0.14, compared to earnings of $0.12 per share in the year-ago period
— Fourth-quarter net revenues surged to $16.3 million from $3.2 million last year
— Gross margin, before fair value changes to biological assets and inventories, dropped to $0.7 million from $1.6 million last year
— Adjusted EBITDA was (-)$7.9 million during the three-month period, compared $0.3 million a year earlier
— In the first quarter of 2020, net revenue is expected to increase sequentially on higher retail sales and wholesale revenue
— First-quarter gross margin, before fair value changes to biological assets and inventories, is anticipated to grow sequentially
— Expects the increased efficiencies and economies of scale to reduce cultivation costs in the first quarter, compared to Q4
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
Comments
Comments are closed.